The table below shows BIOCRYST PHARMACEUTICALS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
$19.07M
$12.27M
$4.48M
$6.41M
$7.23M
$1.55M
Gross profit
-
-
-
-
-
-
R&D
$166.13M
$174.64M
$216.57M
$253.30M
$208.81M
$122.96M
SG&A
$348.65M
BCRX annual revenue (10-K history)
BIOCRYST PHARMACEUTICALS INC reported annual revenue of $25.19M for fiscal year 2017. That is down 4.4% from $26.35M in fiscal 2016. Over the 9 fiscal years shown, annual revenue declined from $74.59M (FY 2009) to $25.19M. Figures come from the company's audited annual reports as filed with the SEC.
